Filtered By:
Source: European Review for Medical and Pharmacological Sciences
Condition: Hemorrhagic Stroke
Drug: Aspirin
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 24 results found since Jan 2013.
Tirofiban in the treatment of cancer-associated ischemic stroke
CONCLUSIONS: Early administration of tirofiban in the treatment of mild to moderate ischemic stroke is safe, which can reduce 24-hour and 7-day NIHSS scores and has potential value.PMID:37140310 | DOI:10.26355/eurrev_202304_32142
Source: European Review for Medical and Pharmacological Sciences - May 4, 2023 Category: Drugs & Pharmacology Authors: Z-M Zhang Z-H Lin G-L Zhu Source Type: research
Effect of tirofiban in treating patients with progressive ischemic stroke
CONCLUSIONS: Tirofiban combined with conventional basic treatment can greatly improve neurological deficits and disease outcomes, alleviate platelet adhesion, and reduce platelet activation without increasing the risk of hemorrhage in PIS patients.PMID:35363359 | DOI:10.26355/eurrev_202203_28357
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: N Du L-X Wang Y-L Liu X-L Yin J-S Zhao L Yang Source Type: research
